Provepharm Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.4M | 193 | 92.8% |
| Consulting Fee | $245,508 | 62 | 6.7% |
| Honoraria | $9,000 | 9 | 0.2% |
| Travel and Lodging | $4,925 | 7 | 0.1% |
| Entertainment | $1,954 | 102 | 0.1% |
| Food and Beverage | $1,591 | 15 | 0.0% |
| Gift | $738.16 | 2 | 0.0% |
| Education | $26.40 | 4 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| PVP-IC1901 | $1.1M | 7 | 71 |
| PVP-2016005 | $853,623 | 0 | 11 |
| PVP-22IC04 and PVP-22IC05 | $635,163 | 3 | 9 |
| Prospective Registry | $231,223 | 1 | 19 |
| Patent Blue V | $109,108 | 1 | 5 |
| PVP2016005 | $74,389 | 0 | 2 |
| MB improves outcomes w/patients with Covid 19 | $70,763 | 0 | 2 |
| PVP-22IC04 | $67,383 | 1 | 26 |
| PVP201603 | $62,694 | 0 | 8 |
| MB as a 3rd line Vasopressor in Septic Shock | $52,047 | 0 | 2 |
| PVP-22IC05 | $30,625 | 1 | 24 |
| MB imPRoves outcomes in PatieNTS with COVID-19 (BLUEPRINT) | $27,338 | 0 | 1 |
| PVP-22IC03 | $6,975 | 1 | 1 |
| PVP-20IC02 | $3,611 | 0 | 1 |
| Sentinel Lymph Node | $2,700 | 1 | 1 |
| PVP2016003 | $2,431 | 0 | 2 |
| MEBIPAM - MEthylene Blue In Patients with Acquired Methemoglobinemia | $2,314 | 1 | 1 |
| 4300-1 | $2,275 | 1 | 1 |
| PVP-2016003 | $1,788 | 0 | 1 |
| PVP20160003 | $1,560 | 0 | 1 |
| PVP-24BD01 | $1,479 | 0 | 1 |
| MB as 3rd line Vasopressor in Septic Shock | $1,350 | 0 | 2 |
| PVP-2016-0005 | $69.90 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Joseph Smith, Md, MD | Urology | Nashville, TN | $1,600 | $0 |
| Eric Rovner, Md, MD | Urology | Charleston, SC | $1,600 | $0 |
| Karim Chamie, M.d, M.D | Surgical Oncology | Los Angeles, CA | $1,600 | $0 |
| Blaise Mooney, M.d, M.D | Diagnostic Radiology | Tampa, FL | $1,480 | $0 |
| Dr. Lauren Prescott, Md, Mph, MD, MPH | Gynecologic Oncology | Nashville, TN | $1,350 | $0 |
| Dr. Frederic Kolb, Md, MD | Plastic Surgery | San Diego, CA | $1,322 | $0 |
| Anirban Mitra, M.d., Ph.d, M.D., PH.D | Urology | Los Angeles, CA | $1,310 | $0 |
| Dr. Liam Hurley, Md, MD | Urology | North Andover, MA | $1,310 | $0 |
| Dr. Jack Andrews, M.d, M.D | Urology | Phoenix, AZ | $1,310 | $0 |
| Dr. Noran Barry, M.d, M.D | Surgical Critical Care | Modesto, CA | $1,300 | $0 |
| Christopher Wanderling, Md, MD | Surgery | Naperville, IL | $1,142 | $0 |
| Dr. David Albala, M.d, M.D | Urology | Syracuse, NY | $1,142 | $0 |
| Ronald Kaufman | Urology | Albany, NY | $1,142 | $0 |
| David Corral, Md, MD | Urology | Moon Twp, PA | $1,142 | $0 |
| Dr. Phillip Smith, Md, MD | Neonatal-Perinatal Medicine | Durham, NC | $1,100 | $0 |
| Steven Fassler, Md, MD | Colon & Rectal Surgery | Abington, PA | $1,100 | $0 |
| Dr. Brian Chapin, Md, MD | Urology | Houston, TX | $1,080 | $0 |
| Stephen Kraus, Md, MD | Urology | San Antonio, TX | $1,080 | $0 |
| Dr. Jedsian Cheng, M.d./M.p.h, M.D./M.P.H | Urology | Houston, TX | $1,080 | $0 |
| James Celebrezze Jr. | Colon & Rectal Surgery | Pittsburgh, PA | $1,000 | $0 |
| Michael Cookson, Md, MD | Urology | Oklahoma City, OK | $1,000 | $0 |
| Dr. Linda Yang, Md, MD | Gynecology | Chicago, IL | $986.60 | $0 |
| Dr. Matthew Rysavy, Md, Phd, MD, PHD | Pediatrics | Houston, TX | $800.00 | $0 |
| Carol Burke, M.d, M.D | Gastroenterology | Cleveland, OH | $750.00 | $0 |
| Nariman Nezami, Md, MD | Diagnostic Radiology | Baltimore, MD | $700.00 | $0 |
Top Products
- BLUDIGO $960,270
- PROVAYBLUE $950,658
Associated Products (6)
- BLUDIGO $960,270
- PROVAYBLUE $950,658
- Indigo Carmine $477,539
- Provayblue $335,195
- METHYLENE BLUE $101,127
- Indigo carmine $13,902
Payment Categories
- Food & Beverage $1,591
- Consulting $245,508
- Travel & Lodging $4,925
- Research $3.4M
About Provepharm Inc.
Provepharm Inc. has made $3.7M in payments to 163 healthcare providers, recorded across 394 transactions in the CMS Open Payments database. In 2024, the company paid $837,332. The top product by payment volume is BLUDIGO ($960,270).
Payments were distributed across 33 medical specialties. The top specialty by payment amount is Internal Medicine ($346,639 to 2 doctors).
Payment categories include: Food & Beverage ($1,591), Consulting ($245,508), Research ($3.4M), Travel & Lodging ($4,925).
Provepharm Inc. is associated with 6 products in the CMS Open Payments database, including BLUDIGO, PROVAYBLUE, and Indigo Carmine.